YOLFTbeta
Neofect Co.Ltd

Neofect Co.Ltd

290660 · KQ · Healthcare / Medical Devices

1,138.00KRW-36.00 (-3.07%)

Price History

Full chart

Market Stats

Previous Close1,174.00
Open1,169.00
Day Range1,129.00 – 1,179.00
52-Week Range1,200.00 – 3,480.00
Volume283.44K
Market Cap55.17B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.43
50-Day Avg1,673.82
200-Day Avg1,818.51

About

Dynamic solution Co.,Ltd. researches, develops, manufactures, and sells rehabilitation medical devices and contents for stroke and spinal cord injuries. The company offers Neofect Smart Glove, a high-tech rehab device that measures movements of the forearm, wrist, and digits with accelerometer and bending sensors; Neofect Smart Kids for hand rehabilitation in children; Neofect Smart Board, a high-tech medical device that develops users' shoulder and upper arm movements to promote improved functional reach and muscle control; Neofect Smart Balance to practice balance and posture during real-world training scenarios; and Neofect Smart Pegboard, a digital pegboard for functional and cognitive rehabilitation. It also provides Neofect Smart Table for dementia prevention and rehabilitation program; Neomano, a wearable robotic glove; Neofect Comcog, a cognitive rehabilitation program that helps patients with stroke, dementia, traumatic brain injury, brain tumor, and cerebral palsy; and Neofect TeleRehab, a teletherapy platform designed for remote rehabilitation, as well as a range of orthotic and assistive devices. The company was formerly known as Neofect Co., Ltd. and changed its name to Dynamic solution Co.,Ltd. in April 2026. The company was incorporated in 2010 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Ho-young Ban
  • Employees57
  • HeadquartersGyeonggi Enterprise Growth Center, Seongnam-si, South Korea, Korea
  • Websitehttps://www.neofect.com

Leadership

  • Mr. Ho-young BanCEO & Executive Director · b. 1977
  • Mr. Yu-Jeong KimMD & Internal Director

Financials

Income Statement

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.98B4.45B5.65B12.31B18.62B23.16B26.20B26.61B21.11B16.05B
Growth (%)-+124.98%+26.91%+117.78%+51.28%+24.34%+13.14%+1.57%-20.67%-23.96%
Cost of Revenue1.00B1.57B1.48B9.08B16.10B16.91B18.71B18.47B11.36B8.52B
Gross Profit975.80M2.88B4.18B3.23B2.53B6.25B7.49B8.14B9.75B7.53B
Gross Margin49.29%64.70%73.88%26.21%13.56%26.97%28.59%30.59%46.18%46.90%
Operating Expense4.52B7.10B9.42B17.29B17.18B13.88B15.24B15.29B7.95B10.43B
Operating Income-3.54B-4.22B-5.24B-14.06B-14.66B-7.63B-7.75B-7.14B1.80B-2.90B
Operating Margin-178.81%-94.79%-92.67%-114.22%-78.70%-32.94%-29.56%-26.85%8.51%-18.08%
EBITDA-------4.40B446.11M3.14B-5.35B
EBITDA Margin-------16.80%1.68%14.86%-33.36%
Net Income-5.92B-4.39B-9.63B-15.84B-15.01B-5.04B-9.62B-4.96B-951.43M-12.30B
Net Income Margin-298.99%-98.54%-170.43%-128.70%-80.58%-21.78%-36.72%-18.65%-4.51%-76.61%
R&D589.23M1.33B915.93M-1.65B1.50B1.94B1.55B1.42B1.57B
R&D as % of Total Revenue29.76%29.82%16.20%-8.88%6.48%7.42%5.81%6.74%9.76%
Interest Expense00001.60B1.70B2.18B3.62B4.18B3.89B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%8.57%7.32%8.34%13.59%19.78%24.22%

Balance Sheet

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets7.93B10.21B35.92B47.02B57.91B52.54B50.37B71.71B72.36B77.79B
Total Liabilities22.10B27.39B7.67B34.60B42.67B40.18B40.80B42.78B33.46B24.61B
Total Equity-14.16B-17.19B28.25B12.41B15.24B12.36B6.48B28.93B38.90B53.33B
Cash1.47B3.90B22.17B2.97B13.74B2.36B1.02B62.00K22.09B32.88B
Total Debt11.59B17.74B4.87B5.61B8.47B-----
Net Debt----8.49B20.03B26.27B3.22B--

Cash Flow

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.92B-7.18B-8.18B-13.92B-9.06B-4.84B-5.70B-4.35B-1.14B-232.76M
Investing Cash Flow-2.73B2.02B-5.06B-23.40B644.20M-5.12B2.50B-1.12B1.66B-
Financing Cash Flow7.85B7.59B31.60B17.89B19.24B-1.68B1.76B21.99B3.80B-
Capital Expenditure809.32M530.27M4.64B8.28B588.66M1.55B393.18M529.91M323.25M2.20B
Free Cash Flow-----10.10B-6.39B-6.09B-4.88B-1.46B-2.44B
Dividends Paid------49.00M0--
FCF to OCF----111.43%132.00%106.90%112.17%128.45%1046.89%
Dividend Paid to FCF-------0.80%0.00%--

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Jun 28, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------
EPS Actual-255.65-439.05-539.98-1119.27-584.81-764.18-617.36-211.07-251.19-348.42-169.82235.78-226.68-171.89-249.23-352.98-170.06-18.14-5.34-231.89-41.1428.17-131.240.20-99.08-653.364.50130.41-150.51-113.79
Surprise------------------------------
Timing--------------------Pre-market---------

Key Statistics & Ratios

Market Cap55.17B
Enterprise Value54.71B
Trailing P/E0.00
Forward P/E0.00
Price / Sales3.65
Price / Book1.10
Revenue (TTM)15.11B
Gross Profit (TTM)7.07B
EBITDA-4.09B
Profit Margin-37.16%
Operating Margin-22.77%
Return on Equity-9.75%
Return on Assets-4.17%
Shares Outstanding42.84M
Shares Float31.10M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 25, 20261:2
  • Sep 29, 2020254:223